First Light (FLAG) announced this morning that it has secured $25 million in additional funding for its combination with clinical-stage drug developer Calidi Biotherapeutics.
The investment is to be led by Jackson Investment Group, which has put forward $5 million as the first stage of a Series B. The remaining $20 million is conditioned upon Calidi closing its combination with First Light and includes some promote shares as an inducement to investors from First Light’s sponsor and Metric Finance Holdings.
The combination did not previously include committed capital provisions, but the parties noted they would seek out a $40 million PIPE at announcement.
The new cash also brings Calidi closer to where it was in a previous SPAC deal announced with EDOC Acquisition Corp. (NASDAQ:ADOC) in March 2022. This included a $25 million PIPE, a $10 million backstop and later a $75 million stock purchase agreement, but it was terminated in August 2022.
Calidi’s new $335 million combination with First Light was announced in January with at a -25% valuation cut from the EDOC deal. But, the new committed capital is nonetheless expected to advance its CLD-101, CLD-201, and CLD-202 drug candidates, which deliver oncolytic viruses for targeted therapy against difficult-to-treat cancers.
Terms Tracker for the Week Ending December 8, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Well that escalated quickly. While last week was quiet, this week was far busier. SPACs saw one IPO start trading after pricing on Friday of...
Mobiv Acquisition Corp. (NASDAQ:MOBV) announced this afternoon that it has closed its combination with EV motorcycle-maker SRIVARU. Shareholders originally approved the deal at a special meeting held back on September 28, but at that time, the parties expected the transaction to take just a week to close. Redemptions whittled Mobiv’s IPO share pool of 10,005,000 down...
Achari Ventures I (NASDAQ:AVHI) has entered into a definitive agreement to combine with medtech firm Vaso Corporation at an equity value of $176 million, or 19.5x its 2022 adjusted EBITDA. Wuxi, China-based Vaso provides IT services and sales support to medical device manufacturers. The combined company is expected to trade on the Nasdaq under the...
EF Hutton Acquisition Corp. I (NASDAQ:EFHT) announced this morning that its shareholders have approved its business combination with E.C.D. Auto Design. At the meeting, there were 5,089,203 shares of common stock, representing approximately 76.82% of the issued and outstanding shares of common stock, present. In connection with the meeting, the company’s stockholders holding 3,470,945 shares,...
Legato Merger Corp. III (NYSE:LEGT) filed for a $175 million IPO yesterday afternoon, becoming the fourth SPAC to file this week. While the other three SPACs that filed their S-1s earlier this week intend to pursue targets in the financial services and biotech industries, Legato III, similar to the earlier Legato SPACs, will focus on...